nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PTGS2—metabolic syndrome X	0.353	0.529	CbGaD
Sulindac—ALB—metabolic syndrome X	0.315	0.471	CbGaD
Sulindac—MAPK3—artery—metabolic syndrome X	0.00944	0.118	CbGeAlD
Sulindac—MAPK3—endothelium—metabolic syndrome X	0.00797	0.0996	CbGeAlD
Sulindac—MAPK3—blood vessel—metabolic syndrome X	0.00735	0.0919	CbGeAlD
Sulindac—AKR1B1—cardiovascular system—metabolic syndrome X	0.00452	0.0565	CbGeAlD
Sulindac—AKR1B1—kidney—metabolic syndrome X	0.00443	0.0553	CbGeAlD
Sulindac—AKR1B1—adipose tissue—metabolic syndrome X	0.00399	0.0499	CbGeAlD
Sulindac—MAPK3—cardiovascular system—metabolic syndrome X	0.00328	0.041	CbGeAlD
Sulindac—MAPK3—kidney—metabolic syndrome X	0.00321	0.0401	CbGeAlD
Sulindac—PPARD—adipose tissue—metabolic syndrome X	0.00314	0.0392	CbGeAlD
Sulindac—MAPK3—adipose tissue—metabolic syndrome X	0.00289	0.0361	CbGeAlD
Sulindac—AKR1B1—liver—metabolic syndrome X	0.0028	0.035	CbGeAlD
Sulindac—PTGS1—artery—metabolic syndrome X	0.00256	0.032	CbGeAlD
Sulindac—PTGS2—artery—metabolic syndrome X	0.00245	0.0306	CbGeAlD
Sulindac—PPARD—liver—metabolic syndrome X	0.0022	0.0275	CbGeAlD
Sulindac—PTGS1—endothelium—metabolic syndrome X	0.00217	0.0271	CbGeAlD
Sulindac—PTGS2—endothelium—metabolic syndrome X	0.00207	0.0259	CbGeAlD
Sulindac—MAPK3—liver—metabolic syndrome X	0.00203	0.0253	CbGeAlD
Sulindac—PTGS1—blood vessel—metabolic syndrome X	0.002	0.025	CbGeAlD
Sulindac—PTGS2—blood vessel—metabolic syndrome X	0.00191	0.0239	CbGeAlD
Sulindac—CYP1A1—kidney—metabolic syndrome X	0.000992	0.0124	CbGeAlD
Sulindac—ALB—liver—metabolic syndrome X	0.000967	0.0121	CbGeAlD
Sulindac—CYP1A1—adipose tissue—metabolic syndrome X	0.000894	0.0112	CbGeAlD
Sulindac—PTGS1—cardiovascular system—metabolic syndrome X	0.000891	0.0111	CbGeAlD
Sulindac—PTGS1—kidney—metabolic syndrome X	0.000872	0.0109	CbGeAlD
Sulindac—PTGS2—cardiovascular system—metabolic syndrome X	0.000852	0.0106	CbGeAlD
Sulindac—PTGS2—kidney—metabolic syndrome X	0.000833	0.0104	CbGeAlD
Sulindac—PTGS1—adipose tissue—metabolic syndrome X	0.000786	0.00982	CbGeAlD
Sulindac—PTGS2—adipose tissue—metabolic syndrome X	0.000751	0.00939	CbGeAlD
Sulindac—CYP1A2—liver—metabolic syndrome X	0.000636	0.00795	CbGeAlD
Sulindac—CYP1A1—liver—metabolic syndrome X	0.000627	0.00784	CbGeAlD
Sulindac—Renal impairment—Metformin—metabolic syndrome X	0.000557	0.0453	CcSEcCtD
Sulindac—PTGS2—liver—metabolic syndrome X	0.000527	0.00658	CbGeAlD
Sulindac—Pancreatitis—Metformin—metabolic syndrome X	0.000449	0.0366	CcSEcCtD
Sulindac—Sweating increased—Metformin—metabolic syndrome X	0.000446	0.0363	CcSEcCtD
Sulindac—Neutropenia—Metformin—metabolic syndrome X	0.000429	0.0349	CcSEcCtD
Sulindac—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000401	0.0326	CcSEcCtD
Sulindac—Hepatitis—Metformin—metabolic syndrome X	0.000367	0.0298	CcSEcCtD
Sulindac—Flushing—Metformin—metabolic syndrome X	0.00034	0.0277	CcSEcCtD
Sulindac—Chills—Metformin—metabolic syndrome X	0.000329	0.0268	CcSEcCtD
Sulindac—Flatulence—Metformin—metabolic syndrome X	0.000315	0.0256	CcSEcCtD
Sulindac—Dysgeusia—Metformin—metabolic syndrome X	0.000313	0.0254	CcSEcCtD
Sulindac—Vision blurred—Metformin—metabolic syndrome X	0.000301	0.0245	CcSEcCtD
Sulindac—Ill-defined disorder—Metformin—metabolic syndrome X	0.000296	0.0241	CcSEcCtD
Sulindac—Malaise—Metformin—metabolic syndrome X	0.000288	0.0234	CcSEcCtD
Sulindac—Syncope—Metformin—metabolic syndrome X	0.000286	0.0233	CcSEcCtD
Sulindac—Palpitations—Metformin—metabolic syndrome X	0.000282	0.023	CcSEcCtD
Sulindac—Loss of consciousness—Metformin—metabolic syndrome X	0.000281	0.0228	CcSEcCtD
Sulindac—Hypertension—Metformin—metabolic syndrome X	0.000276	0.0224	CcSEcCtD
Sulindac—Myalgia—Metformin—metabolic syndrome X	0.000272	0.0221	CcSEcCtD
Sulindac—Chest pain—Metformin—metabolic syndrome X	0.000272	0.0221	CcSEcCtD
Sulindac—Discomfort—Metformin—metabolic syndrome X	0.000269	0.0219	CcSEcCtD
Sulindac—Oedema—Metformin—metabolic syndrome X	0.000261	0.0212	CcSEcCtD
Sulindac—Shock—Metformin—metabolic syndrome X	0.000256	0.0209	CcSEcCtD
Sulindac—Thrombocytopenia—Metformin—metabolic syndrome X	0.000255	0.0208	CcSEcCtD
Sulindac—Hyperhidrosis—Metformin—metabolic syndrome X	0.000252	0.0205	CcSEcCtD
Sulindac—Anorexia—Metformin—metabolic syndrome X	0.000248	0.0202	CcSEcCtD
Sulindac—Hypotension—Metformin—metabolic syndrome X	0.000244	0.0198	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000237	0.0193	CcSEcCtD
Sulindac—Paraesthesia—Metformin—metabolic syndrome X	0.000234	0.019	CcSEcCtD
Sulindac—Dyspnoea—Metformin—metabolic syndrome X	0.000232	0.0189	CcSEcCtD
Sulindac—Somnolence—Metformin—metabolic syndrome X	0.000232	0.0188	CcSEcCtD
Sulindac—Dyspepsia—Metformin—metabolic syndrome X	0.000229	0.0187	CcSEcCtD
Sulindac—Decreased appetite—Metformin—metabolic syndrome X	0.000227	0.0184	CcSEcCtD
Sulindac—Fatigue—Metformin—metabolic syndrome X	0.000225	0.0183	CcSEcCtD
Sulindac—Constipation—Metformin—metabolic syndrome X	0.000223	0.0181	CcSEcCtD
Sulindac—Feeling abnormal—Metformin—metabolic syndrome X	0.000215	0.0175	CcSEcCtD
Sulindac—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000213	0.0173	CcSEcCtD
Sulindac—Urticaria—Metformin—metabolic syndrome X	0.000207	0.0168	CcSEcCtD
Sulindac—Asthenia—Metformin—metabolic syndrome X	0.000187	0.0152	CcSEcCtD
Sulindac—Pruritus—Metformin—metabolic syndrome X	0.000184	0.015	CcSEcCtD
Sulindac—Diarrhoea—Metformin—metabolic syndrome X	0.000178	0.0145	CcSEcCtD
Sulindac—Dizziness—Metformin—metabolic syndrome X	0.000172	0.014	CcSEcCtD
Sulindac—Vomiting—Metformin—metabolic syndrome X	0.000166	0.0135	CcSEcCtD
Sulindac—Rash—Metformin—metabolic syndrome X	0.000164	0.0134	CcSEcCtD
Sulindac—Dermatitis—Metformin—metabolic syndrome X	0.000164	0.0134	CcSEcCtD
Sulindac—Headache—Metformin—metabolic syndrome X	0.000163	0.0133	CcSEcCtD
Sulindac—Nausea—Metformin—metabolic syndrome X	0.000155	0.0126	CcSEcCtD
Sulindac—PTGS2—Disease—HMGA1—metabolic syndrome X	2.36e-05	9.84e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PLA2G6—metabolic syndrome X	2.34e-05	9.75e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.32e-05	9.68e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TGFB1—metabolic syndrome X	2.31e-05	9.66e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOA5—metabolic syndrome X	2.31e-05	9.65e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—G6PD—metabolic syndrome X	2.31e-05	9.62e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.28e-05	9.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TGFB1—metabolic syndrome X	2.27e-05	9.47e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HDAC3—metabolic syndrome X	2.25e-05	9.39e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—GOT2—metabolic syndrome X	2.25e-05	9.39e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.25e-05	9.38e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	2.25e-05	9.37e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CYBA—metabolic syndrome X	2.24e-05	9.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—APOE—metabolic syndrome X	2.22e-05	9.26e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCL2—metabolic syndrome X	2.21e-05	9.22e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.2e-05	9.19e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCKR—metabolic syndrome X	2.2e-05	9.18e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—LPA—metabolic syndrome X	2.2e-05	9.18e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—APOA1—metabolic syndrome X	2.19e-05	9.15e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—APOA1—metabolic syndrome X	2.18e-05	9.1e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.18e-05	9.08e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NAMPT—metabolic syndrome X	2.17e-05	9.07e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.16e-05	9.02e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—metabolic syndrome X	2.16e-05	9.02e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—LIPC—metabolic syndrome X	2.16e-05	9.01e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GCK—metabolic syndrome X	2.16e-05	9.01e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TRIB3—metabolic syndrome X	2.15e-05	8.98e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOC3—metabolic syndrome X	2.15e-05	8.96e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IRS1—metabolic syndrome X	2.14e-05	8.95e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.14e-05	8.94e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.13e-05	8.91e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PLA2G6—metabolic syndrome X	2.13e-05	8.89e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	2.12e-05	8.84e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC2A4—metabolic syndrome X	2.12e-05	8.83e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ABCA1—metabolic syndrome X	2.12e-05	8.83e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.12e-05	8.83e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOA5—metabolic syndrome X	2.11e-05	8.8e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CETP—metabolic syndrome X	2.08e-05	8.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PPARG—metabolic syndrome X	2.08e-05	8.69e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.07e-05	8.63e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GGT1—metabolic syndrome X	2.05e-05	8.55e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GOT1—metabolic syndrome X	2.05e-05	8.55e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.05e-05	8.55e-05	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	2.05e-05	8.54e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—metabolic syndrome X	2.02e-05	8.43e-05	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.01e-05	8.39e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.01e-05	8.38e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC2A4—metabolic syndrome X	2.01e-05	8.37e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF2—metabolic syndrome X	2e-05	8.34e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SCARB1—metabolic syndrome X	2e-05	8.33e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.98e-05	8.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IRS1—metabolic syndrome X	1.98e-05	8.26e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—TRIB3—metabolic syndrome X	1.96e-05	8.18e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.94e-05	8.11e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—GOT1—metabolic syndrome X	1.94e-05	8.11e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOB—metabolic syndrome X	1.94e-05	8.1e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SREBF1—metabolic syndrome X	1.94e-05	8.08e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NAMPT—metabolic syndrome X	1.93e-05	8.05e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.92e-05	8e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—LIPC—metabolic syndrome X	1.92e-05	8e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GCK—metabolic syndrome X	1.92e-05	8e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—FABP4—metabolic syndrome X	1.91e-05	7.97e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOC3—metabolic syndrome X	1.91e-05	7.95e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL5—metabolic syndrome X	1.9e-05	7.91e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—INS—metabolic syndrome X	1.9e-05	7.91e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.89e-05	7.88e-05	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.89e-05	7.87e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GOT2—metabolic syndrome X	1.88e-05	7.86e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HMGCR—metabolic syndrome X	1.88e-05	7.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—SERPINE1—metabolic syndrome X	1.88e-05	7.82e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AKT1—metabolic syndrome X	1.86e-05	7.78e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LPL—metabolic syndrome X	1.85e-05	7.73e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CETP—metabolic syndrome X	1.85e-05	7.72e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IGF1—metabolic syndrome X	1.82e-05	7.6e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	1.81e-05	7.55e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SCARB1—metabolic syndrome X	1.77e-05	7.39e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NAMPT—metabolic syndrome X	1.76e-05	7.34e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.75e-05	7.32e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.75e-05	7.3e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—LIPC—metabolic syndrome X	1.75e-05	7.29e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCK—metabolic syndrome X	1.75e-05	7.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—metabolic syndrome X	1.74e-05	7.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—SERPINE1—metabolic syndrome X	1.74e-05	7.26e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOB—metabolic syndrome X	1.74e-05	7.26e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOC3—metabolic syndrome X	1.74e-05	7.25e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SERPINE1—metabolic syndrome X	1.73e-05	7.22e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.72e-05	7.2e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SREBF1—metabolic syndrome X	1.72e-05	7.18e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.71e-05	7.12e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PLA2G4A—metabolic syndrome X	1.69e-05	7.06e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CETP—metabolic syndrome X	1.69e-05	7.04e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC2A4—metabolic syndrome X	1.68e-05	7.01e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ABCA1—metabolic syndrome X	1.68e-05	7.01e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.68e-05	6.99e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HMGCR—metabolic syndrome X	1.67e-05	6.98e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GOT2—metabolic syndrome X	1.67e-05	6.98e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—metabolic syndrome X	1.66e-05	6.94e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—LPL—metabolic syndrome X	1.66e-05	6.93e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—metabolic syndrome X	1.65e-05	6.89e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOB—metabolic syndrome X	1.65e-05	6.88e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GGT1—metabolic syndrome X	1.63e-05	6.79e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GOT1—metabolic syndrome X	1.63e-05	6.79e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—SCARB1—metabolic syndrome X	1.61e-05	6.74e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—G6PD—metabolic syndrome X	1.61e-05	6.73e-05	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—AKT1—metabolic syndrome X	1.61e-05	6.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—AKT1—metabolic syndrome X	1.61e-05	6.71e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.59e-05	6.64e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGT—metabolic syndrome X	1.59e-05	6.62e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—AKT1—metabolic syndrome X	1.58e-05	6.59e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CD36—metabolic syndrome X	1.58e-05	6.58e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	1.57e-05	6.57e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—LPL—metabolic syndrome X	1.57e-05	6.57e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—SREBF1—metabolic syndrome X	1.57e-05	6.54e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LEP—metabolic syndrome X	1.55e-05	6.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOE—metabolic syndrome X	1.55e-05	6.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—metabolic syndrome X	1.54e-05	6.43e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCKR—metabolic syndrome X	1.54e-05	6.42e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPA—metabolic syndrome X	1.54e-05	6.42e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOA1—metabolic syndrome X	1.54e-05	6.41e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GOT2—metabolic syndrome X	1.53e-05	6.36e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMGCR—metabolic syndrome X	1.53e-05	6.36e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—metabolic syndrome X	1.52e-05	6.34e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.51e-05	6.3e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ABCA1—metabolic syndrome X	1.49e-05	6.22e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC2A4—metabolic syndrome X	1.49e-05	6.22e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	1.49e-05	6.22e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.48e-05	6.17e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOA5—metabolic syndrome X	1.48e-05	6.16e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	1.47e-05	6.15e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARA—metabolic syndrome X	1.47e-05	6.12e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GOT1—metabolic syndrome X	1.44e-05	6.03e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GGT1—metabolic syndrome X	1.44e-05	6.03e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.43e-05	5.98e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—AKT1—metabolic syndrome X	1.42e-05	5.93e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AGT—metabolic syndrome X	1.42e-05	5.93e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.4e-05	5.86e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOE—metabolic syndrome X	1.39e-05	5.81e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.39e-05	5.79e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IRS1—metabolic syndrome X	1.39e-05	5.78e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOB—metabolic syndrome X	1.38e-05	5.76e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOA1—metabolic syndrome X	1.38e-05	5.74e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.38e-05	5.74e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	1.37e-05	5.72e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ABCA1—metabolic syndrome X	1.36e-05	5.67e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC2A4—metabolic syndrome X	1.36e-05	5.67e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PLA2G4A—metabolic syndrome X	1.34e-05	5.6e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—INS—metabolic syndrome X	1.33e-05	5.54e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOE—metabolic syndrome X	1.32e-05	5.51e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—LPL—metabolic syndrome X	1.32e-05	5.5e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GGT1—metabolic syndrome X	1.32e-05	5.49e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GOT1—metabolic syndrome X	1.32e-05	5.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL2—metabolic syndrome X	1.31e-05	5.45e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOA1—metabolic syndrome X	1.3e-05	5.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1—metabolic syndrome X	1.28e-05	5.36e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AKT1—metabolic syndrome X	1.25e-05	5.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CD36—metabolic syndrome X	1.25e-05	5.23e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	1.23e-05	5.13e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOB—metabolic syndrome X	1.23e-05	5.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.22e-05	5.1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LIPC—metabolic syndrome X	1.22e-05	5.1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCK—metabolic syndrome X	1.22e-05	5.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.22e-05	5.09e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOC3—metabolic syndrome X	1.21e-05	5.07e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—metabolic syndrome X	1.21e-05	5.06e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PLA2G4A—metabolic syndrome X	1.19e-05	4.97e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—INS—metabolic syndrome X	1.19e-05	4.96e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CETP—metabolic syndrome X	1.18e-05	4.92e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IRS1—metabolic syndrome X	1.18e-05	4.91e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—LPL—metabolic syndrome X	1.17e-05	4.88e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARA—metabolic syndrome X	1.16e-05	4.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—metabolic syndrome X	1.16e-05	4.86e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	1.13e-05	4.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AGT—metabolic syndrome X	1.13e-05	4.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—INS—metabolic syndrome X	1.13e-05	4.7e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOB—metabolic syndrome X	1.12e-05	4.66e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CD36—metabolic syndrome X	1.11e-05	4.64e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOE—metabolic syndrome X	1.11e-05	4.61e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.1e-05	4.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—metabolic syndrome X	1.1e-05	4.59e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	1.1e-05	4.58e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOA1—metabolic syndrome X	1.09e-05	4.56e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—metabolic syndrome X	1.09e-05	4.56e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—metabolic syndrome X	1.09e-05	4.55e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PLA2G4A—metabolic syndrome X	1.09e-05	4.53e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.07e-05	4.45e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.07e-05	4.45e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—LPL—metabolic syndrome X	1.07e-05	4.45e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—metabolic syndrome X	1.04e-05	4.35e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SERPINE1—metabolic syndrome X	1.04e-05	4.32e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARA—metabolic syndrome X	1.03e-05	4.31e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CD36—metabolic syndrome X	1.01e-05	4.23e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AGT—metabolic syndrome X	1e-05	4.18e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—metabolic syndrome X	9.89e-06	4.12e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—metabolic syndrome X	9.82e-06	4.1e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOE—metabolic syndrome X	9.81e-06	4.09e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOA1—metabolic syndrome X	9.7e-06	4.05e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—metabolic syndrome X	9.63e-06	4.02e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	9.62e-06	4.01e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—metabolic syndrome X	9.54e-06	3.98e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	9.51e-06	3.97e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	9.51e-06	3.97e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—INS—metabolic syndrome X	9.44e-06	3.94e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARA—metabolic syndrome X	9.42e-06	3.93e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GGT1—metabolic syndrome X	9.21e-06	3.84e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GOT1—metabolic syndrome X	9.21e-06	3.84e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—AGT—metabolic syndrome X	9.12e-06	3.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AKT1—metabolic syndrome X	9.06e-06	3.78e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—metabolic syndrome X	8.97e-06	3.74e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOE—metabolic syndrome X	8.94e-06	3.73e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOA1—metabolic syndrome X	8.84e-06	3.69e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—metabolic syndrome X	8.65e-06	3.61e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—metabolic syndrome X	8.54e-06	3.56e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—INS—metabolic syndrome X	8.38e-06	3.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—metabolic syndrome X	8.28e-06	3.46e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—metabolic syndrome X	8.28e-06	3.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AKT1—metabolic syndrome X	8.28e-06	3.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—AKT1—metabolic syndrome X	8.23e-06	3.43e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOB—metabolic syndrome X	7.81e-06	3.26e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—metabolic syndrome X	7.79e-06	3.25e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—metabolic syndrome X	7.7e-06	3.21e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—metabolic syndrome X	7.68e-06	3.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—AKT1—metabolic syndrome X	7.64e-06	3.19e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—INS—metabolic syndrome X	7.64e-06	3.19e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	7.6e-06	3.17e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—AKT1—metabolic syndrome X	7.59e-06	3.17e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPL—metabolic syndrome X	7.46e-06	3.11e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—metabolic syndrome X	7.35e-06	3.07e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CD36—metabolic syndrome X	7.09e-06	2.96e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—metabolic syndrome X	6.72e-06	2.8e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—metabolic syndrome X	6.7e-06	2.79e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARA—metabolic syndrome X	6.59e-06	2.75e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—metabolic syndrome X	6.54e-06	2.73e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AGT—metabolic syndrome X	6.38e-06	2.66e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOE—metabolic syndrome X	6.25e-06	2.61e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOA1—metabolic syndrome X	6.18e-06	2.58e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—metabolic syndrome X	6.13e-06	2.56e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—metabolic syndrome X	5.8e-06	2.42e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—metabolic syndrome X	5.45e-06	2.27e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT1—metabolic syndrome X	5.35e-06	2.23e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—INS—metabolic syndrome X	5.34e-06	2.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—metabolic syndrome X	4.93e-06	2.06e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—metabolic syndrome X	4.9e-06	2.04e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AKT1—metabolic syndrome X	4.79e-06	2e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—metabolic syndrome X	4.68e-06	1.95e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT1—metabolic syndrome X	4.54e-06	1.9e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	4.28e-06	1.79e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AKT1—metabolic syndrome X	3.81e-06	1.59e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AKT1—metabolic syndrome X	3.38e-06	1.41e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—AKT1—metabolic syndrome X	3.08e-06	1.28e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.15e-06	8.99e-06	CbGpPWpGaD
